Table 4.
NVC alterations in APS and "aPL carriers" groups and their correlation with aPL isotypes
| Microhemorrhages | p-value | "Comb-like" | p-value | |
|---|---|---|---|---|
| Total number | 20 | 12 | ||
| Any positive IgG (%) | 8 (40.0) | 0.906 | 3 (25.0) | 0.526 |
| Any positive IgM (%) | 13 (65.0) | 0.845 | 9 (75.0) | 0.405 |
| Any positive anti-b2GPI (%) | 16 (80.0) | 0.541 | 9 (75.0) | 1 |
| Any positive ACL (%) | 12 (60.0) | 1 | 7 (58.3) | 1 |
| Positive ACL IgG (%) | 7 (35.0) | 0.915 | 3 (25.0) | 0.822 |
| Positive ACL IgM (%) | 8 (40.0) | 0.659 | 6 (50.0) | 0.31 |
| Positive anti-b2GPI IgG (%) | 7 (35.0) | 0.915 | 3 (25.0) | 0.822 |
| Positive anti-b2GPI IgM (%) | 12 (60.0) | 0.276 | 8 (66.7) | 0.258 |
| Positive LAC (%) | 4 (20.0) | 0.783 | 3 (25.0) | 1 |
ACL: anticardiolipin antibodies, anti-b2GPI: antibeta2 glycoprotein I antibodies, LAC: lupus anticoagulant